Neil Savage

Hamilton, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 146 publications

Smaller reactors bring nuclear power closer to fulfilling its promise.

Smaller reactors bring nuclear power closer to fulfilling its promise.

Journal: Nature
Published: August 26, 2026

The 46 companies scrambling to commercialize fusion for energy.

The 46 companies scrambling to commercialize fusion for energy.

Journal: Nature
Published: August 26, 2026

A raft of start-up firms is betting on nuclear fusion.

A raft of start-up firms is betting on nuclear fusion.

Journal: Nature
Published: August 26, 2026

Five ways 3D printing is improving lab work.

Five ways 3D printing is improving lab work.

Journal: Nature
Published: August 19, 2026

uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell target.

uPAR is highly expressed in recurrent glioblastoma and represents a candidate CAR T cell target.

Journal: Science translational medicine
Published: May 13, 2026

Technologies to give a clearer view of the lungs.

Technologies to give a clearer view of the lungs.

Journal: Nature
Published: January 28, 2026

Light could lower AI's appetite for power.

Light could lower AI's appetite for power.

Journal: Nature nanotechnology
Published: January 20, 2026

A universal flu vaccine has proved challenging - could it finally be possible?

A universal flu vaccine has proved challenging - could it finally be possible?

Journal: Nature
Published: December 17, 2025

Data drive city transportation forwards.

Data drive city transportation forwards.

Journal: Nature
Published: December 03, 2025

CRISPR screen reveals SOX2 as a critical regulator of CD133 and cellular stress response in glioblastoma.

CRISPR screen reveals SOX2 as a critical regulator of CD133 and cellular stress response in glioblastoma.

Journal: Scientific reports
Published: May 29, 2025

AI listens for health conditions.

AI listens for health conditions.

Journal: Nature
Published: May 22, 2025

Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid Tumors.

Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid Tumors.

Journal: Cancer immunology research
Published: April 22, 2025
Showing 1-12 of 146

Last Updated: 09/26/2026